• Most Popular
  • Most Shared

Sun Pharma gets U.S. nod for prostate cancer drug

Tue Jul 7, 2009 10:59am EDT

Stocks

   

BANGALORE, July 7 (Reuters) - India's Sun Pharmaceutical Industries Ltd (SUN.BO) said on Tuesday it had received approval from the U.S. Food and Drug Administration to launch generic version of AstraZeneca Plc's (AZN.L) prostate cancer drug Casodex.

Stocks

The Indian drug maker said in a statement that AstraZeneca (AZN.L) had annual sales of Casodex of $314 million in the United States.

Ahead of the announcement, shares in Sun Pharma rose 1.2 percent to 1,143.35 rupees in the main Mumbai market .BSESN that ended 0.9 percent higher. (Reporting by Sumeet Chatterjee; Editing by David Cowell)

Stocks


More from Reuters

Photo

Bernanke: trial reserve drains may launch exit

WASHINGTON (Reuters) - The Federal Reserve could begin pulling back its unprecedented stimulus for the U.S. economy by first removing some cash from the financial system and then raising interest rates, Fed Chairman Ben Bernanke said on Wednesday.

» More Top News
A protester marches next to a banner during an anti-government rally in Athens February 10, 2010. REUTERS/John Kolesidis
Analysis:

Will IMF step in on Greece?

Europe is loathe to turn to the International Monetary Fund to help bail out Greece but it may have little choice.  Full Article 

Global Markets
A worker drives a Toyota Motor Corp's newly assembled Prius hybrid vehicle onto a trailer near the company's plant in Toyota, central Japan February 9, 2010.REUTERS/Yuriko Nakao
Reuters Breakingviews:

Toyota's troubles in overdrive

The cost of Toyota's recall nightmare is nothing compared to the price of fixing its battered reputation.  Commentary 

Autos